These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 20709508)

  • 1. [Characteristics of tuberous sclerosis in children].
    Riquet A; Cuisset JM; Cuvellier JC; Joriot S; Petit F; Vallée L
    Arch Pediatr; 2010 Sep; 17(9):1338-45. PubMed ID: 20709508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Care continuity for patients with tuberous sclerosis complex (TSC) during transition from childhood to adulthood].
    Kiyoko S; Hitoshi O
    Nihon Rinsho; 2010 Jan; 68(1):136-40. PubMed ID: 20077806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberous sclerosis.
    Curatolo P; Bombardieri R; Jozwiak S
    Lancet; 2008 Aug; 372(9639):657-68. PubMed ID: 18722871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and genotypic characterization of Chinese children diagnosed with tuberous sclerosis complex.
    Yang G; Shi ZN; Meng Y; Shi XY; Pang LY; Ma SF; Zhang MN; Wang YY; Zou LP
    Clin Genet; 2017 May; 91(5):764-768. PubMed ID: 27859028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberous sclerosis complex.
    Islam MP; Roach ES
    Handb Clin Neurol; 2015; 132():97-109. PubMed ID: 26564073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging treatments in the management of tuberous sclerosis complex.
    Kohrman MH
    Pediatr Neurol; 2012 May; 46(5):267-75. PubMed ID: 22520346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying the Lessons of Tuberous Sclerosis: The 2015 Hower Award Lecture.
    Roach ES
    Pediatr Neurol; 2016 Oct; 63():6-22. PubMed ID: 27543366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tuberous sclerosis complex: A review].
    Pfirmann P; Combe C; Rigothier C
    Rev Med Interne; 2021 Oct; 42(10):714-721. PubMed ID: 33836894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberous Sclerosis Complex: A Review.
    Randle SC
    Pediatr Ann; 2017 Apr; 46(4):e166-e171. PubMed ID: 28414398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of manifestations in tuberous sclerosis complex in relation to genotype.
    Kothare SV; Singh K; Chalifoux JR; Staley BA; Weiner HL; Menzer K; Devinsky O
    Epilepsia; 2014 Jul; 55(7):1025-9. PubMed ID: 24917535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberous sclerosis complex: Recent advances in manifestations and therapy.
    Wataya-Kaneda M; Uemura M; Fujita K; Hirata H; Osuga K; Kagitani-Shimono K; Nonomura N;
    Int J Urol; 2017 Sep; 24(9):681-691. PubMed ID: 28667702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and genetic study patients with tuberous sclerosis complex].
    Rubilar C; López F; Troncoso M; Barrios A; Herrera L
    Rev Chil Pediatr; 2017 Feb; 88(1):41-49. PubMed ID: 28288225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of paediatric patients with tuberous sclerosis complex in Korea: genotype and epilepsy.
    Lee JS; Lim BC; Chae JH; Hwang YS; Seong MW; Park SS; Kim KJ
    Epileptic Disord; 2014 Dec; 16(4):449-55. PubMed ID: 25498131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of epilepsy in tuberous sclerosis complex.
    Curatolo P; D'Argenzio L; Cerminara C; Bombardieri R
    Expert Rev Neurother; 2008 Mar; 8(3):457-67. PubMed ID: 18345974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic update in tuberous sclerosis complex: the role of mTOR pathway inhibitors].
    Ruiz-Falcó Rojas ML
    Rev Neurol; 2012 May; 54 Suppl 3():S19-24. PubMed ID: 22605628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study.
    Gupta A; de Bruyn G; Tousseyn S; Krishnan B; Lagae L; Agarwal N;
    Pediatr Neurol; 2020 May; 106():10-16. PubMed ID: 32139167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intellectual abilities in tuberous sclerosis complex: risk factors and correlates from the Tuberous Sclerosis 2000 Study.
    Bolton PF; Clifford M; Tye C; Maclean C; Humphrey A; le Maréchal K; Higgins JN; Neville BG; Rijsdjik F; ; Yates JR
    Psychol Med; 2015 Aug; 45(11):2321-31. PubMed ID: 25827976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberous Sclerosis Complex: Genetic counselling and perinatal follow-up.
    Touraine R; Hauet Q; Harzallah I; Baruteau AE
    Arch Pediatr; 2022 Dec; 29(5S):5S3-5S7. PubMed ID: 36585068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings.
    Aronow ME; Nakagawa JA; Gupta A; Traboulsi EI; Singh AD
    Ophthalmology; 2012 Sep; 119(9):1917-23. PubMed ID: 22608477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tuberous Sclerosis 2000 Study: presentation, initial assessments and implications for diagnosis and management.
    Yates JR; Maclean C; Higgins JN; Humphrey A; le Maréchal K; Clifford M; Carcani-Rathwell I; Sampson JR; Bolton PF;
    Arch Dis Child; 2011 Nov; 96(11):1020-5. PubMed ID: 21813552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.